Natco Pharma · NSE: NATCOPHARM · BSE: 524816
Q1 FY19 results · Apr–Jun 2018
Natco Pharma reported revenue from operations of ₹538.60 crore and net profit of ₹181.10 crore for Q1 FY19 (Apr–Jun 2018), on a consolidated basis.
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 538.60 | — | — | — | — |
| Other income | 35.90 | — | — | — | — |
| Total income | 574.50 | — | — | — | — |
| Profit before tax | 232.30 | — | — | — | — |
| Net profit for the period | 181.10 | — | — | — | — |
| Attributable to shareholders of the company | 181.60 | — | — | — | — |
| EPS, basic (₹) | 9.84 | — | — | — | — |
| Net margin (%) | 33.6 | — | — |
| Item | Q1 FY19 | Q1 FY18 | YoY | Q4 FY18 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 515.70 | — | — | — | — |
| Other income | 35.70 | — | — | — | — |
| Total income | 551.40 | — | — | — | — |
| Profit before tax | 239.80 | — | — | — | — |
| Net profit for the period | 188.60 | — | — | — | — |
| EPS, basic (₹) | 10.22 | — | — | — | — |
| Net margin (%) | 36.6 | — | — |
Consolidated
- Filed with BSE
- 08 Aug 2018, 17:56 IST
- Board meeting
- 08 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 08 Aug 2018, 17:56 IST
- Board meeting
- 08 Aug 2018
- Period
- 01 Apr 2018 to 30 Jun 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE